Literature DB >> 6707904

Noncompartmental determination of the steady-state volume of distribution during multiple dosing.

I L Smith, J J Schentag.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6707904     DOI： 10.1002/jps.2600730239

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  22 in total

1.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Simple methods for estimation of mean residence time and steady-state volume of distribution from continuous-infusion data.

Authors:  W R Gillespie
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

3.  Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.

Authors:  D Bérubé; F Vallée; A C Panneton; M G Bergeron; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

4.  Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients.

Authors:  M LeBel; M G Bergeron; F Vallée; C Fiset; G Chassé; P Bigonesse; G Rivard
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

5.  Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.

Authors:  S C Chien; F A Wong; C L Fowler; S V Callery-D'Amico; R R Williams; R Nayak; A T Chow
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

6.  Bioelectrical impedance modelling of gentamicin pharmacokinetic parameters.

Authors:  B J Zarowitz; A M Pilla; E L Peterson
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

7.  Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.

Authors:  S D Goodwin; H A Gallis; A T Chow; F A Wong; S C Flor; J A Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Vancomycin pharmacokinetics in burn patients and intravenous drug abusers.

Authors:  M J Rybak; L M Albrecht; J R Berman; L H Warbasse; C K Svensson
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

9.  Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.

Authors:  C R Marchbanks; D J Mikolich; K H Mayer; S H Zinner; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

10.  Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.

Authors:  A S Benko; D M Cappelletty; J A Kruse; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.